Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment
  1. Outputs

Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature

Academic Article
Publication Date:
2024
Short description:
Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature / Regoni, M., Valtorta, F., Sassone, J.. - In: EUROPEAN JOURNAL OF NEUROSCIENCE. - ISSN 0953-816X. - 59:6(2024), pp. 1079-1098. [10.1111/ejn.16136]
abstract:
: Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive dysfunction and loss of dopaminergic neurons of the substantia nigra pars compacta (SNc). Several pathways of programmed cell death are likely to play a role in dopaminergic neuron death, such as apoptosis, necrosis, pyroptosis and ferroptosis, as well as cell death associated with proteasomal and mitochondrial dysfunction. A better understanding of the molecular mechanisms underlying dopaminergic neuron death could inform the design of drugs that promote neuron survival. Necroptosis is a recently characterized regulated cell death mechanism that exhibits morphological features common to both apoptosis and necrosis. It requires activation of an intracellular pathway involving receptor-interacting protein 1 kinase (RIP1 kinase, RIPK1), receptor-interacting protein 3 kinase (RIP3 kinase, RIPK3) and mixed lineage kinase domain-like pseudokinase (MLKL). The potential involvement of this programmed cell death pathway in the pathogenesis of PD has been studied by analysing biomarkers for necroptosis, such as the levels and oligomerization of phosphorylated RIPK3 (pRIPK3) and phosphorylated MLKL (pMLKL), in several PD preclinical models and in PD human tissue. Although there is evidence that other types of cell death also have a role in DA neuron death, most studies support the hypothesis that this cell death mechanism is activated in PD tissues. Drugs that prevent or reduce necroptosis may provide neuroprotection for PD. In this review, we summarize the findings from these studies. We also discuss how manipulating necroptosis might open a novel therapeutic approach to reduce neuronal degeneration in PD.
Iris type:
1.1.1 Articolo in rivista - Review
List of contributors:
Regoni, M.; Valtorta, F.; Sassone, J.
Authors of the University:
REGONI MARIA
SASSONE PAGANO JENNY
VALTORTA FLAVIA
Handle:
https://iris.unisr.it/handle/20.500.11768/164417
Full Text:
https://iris.unisr.it//retrieve/handle/20.500.11768/164417/222642/Eur%20J%20of%20Neuroscience%20-%202023%20-%20Regoni%20-%20Dopaminergic%20neuronal%20death%20via%20necroptosis%20in%20Parkinson%20s%20disease%20A%20review%20of%20the.pdf
Published in:
EUROPEAN JOURNAL OF NEUROSCIENCE
Journal
  • Overview

Overview

URL

https://pubmed.ncbi.nlm.nih.gov/37667848/
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.11.1.0